En raison de la grève de Postes Canada, il y aura un délai dans la livraison des livres.

Insurers must manage drug cost inflation in 2025

Costly new drugs are proliferating.

HEALTH | January 21 2025 10:55AM
Canadian medicine prices remain higher than all price board reference countries

Patented medicines make up approximately 47 per cent of all drug sales in Canada.

HEALTH | December 11 2024 10:00AM
Health Canada approval rate for medicines edges above five-year average

Patented Medicine Prices Review Board looks at Canadian sales of new medicines.

HEALTH | May 28 2024 10:36AM
Canadian list prices for patented medicines remain among the highest in the world

Annual report of the Patented Medicine Prices Review Board tabled in House of Commons.

HEALTH | February 20 2024 10:10AM
Public drug plans not immune to the rising cost of medications

Costs grew faster in 2021-2022 than in the previous five years.

HEALTH | January 17 2024 10:55AM
Advertisement
Industry advises Patented Medicines Pricing Review Board on new guidelines

Response to agency’s scoping paper encourages industry’s involvement in pricing review.

HEALTH | December 22 2023 10:52AM
Government forms Canadian Drug Agency

Once established, agency is expected to take a greater role in Canada’s drug system.

HEALTH | December 20 2023 10:55AM